» Articles » PMID: 9233462

HIV-associated Brain Pathology in the United Kingdom: an Epidemiological Study

Overview
Journal AIDS
Date 1997 Jul 15
PMID 9233462
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To examine the epidemiology of HIV-associated neuropathology in the United Kingdom and to investigate whether the prevalence of different forms of HIV-associated brain pathology varies with exposure category.

Design: The study was a cross-sectional survey; data was analysed from the Medical Research Council National AIDS Neuropathology database.

Setting: Information was gathered from throughout England, Scotland and Wales.

Subjects: Individuals who died from AIDS in the United Kingdom and had a postmortem examination. The database comprised 7% of all AIDS deaths in the United Kingdom between 1982 and 1993.

Main Outcome: Neuropathological diagnoses based on internationally accepted neuropathological terminology of AIDS-related brain lesions.

Results: HIV encephalitis was the most prevalent pathological diagnosis, occurring in 25.3% [95% confidence interval (CI), 21.0-29.6] of the study sample. Statistically significant independent associations for the occurrence of HIV encephalitis were found for injecting drug use (odds ratio, 6.86; 95% CI, 2.91-16.17), and age less than 30 years at death (odds ratio, 3.58; 95% CI, 1.99-6.44). Vascular lesions were significantly higher among blood product recipients, 95% of whom were haemophiliacs.

Conclusions: This was the first epidemiological investigation of HIV-associated brain pathology in the United Kingdom. HIV encephalitis appeared to occur more frequently in injecting drug users and those who died younger. Whereas the findings must be interpreted cautiously, one hypothesis was that differences in the route of transmission may have affected the manifestation of HIV-associated brain damage.

Citing Articles

HIV integration in the human brain is linked to microglial activation and 3D genome remodeling.

Plaza-Jennings A, Valada A, OShea C, Iskhakova M, Hu B, Javidfar B Mol Cell. 2022; 82(24):4647-4663.e8.

PMID: 36525955 PMC: 9831062. DOI: 10.1016/j.molcel.2022.11.016.


MRI imaging features of HIV-related central nervous system diseases: diagnosis by pattern recognition in daily practice.

Sakai M, Higashi M, Fujiwara T, Uehira T, Shirasaka T, Nakanishi K Jpn J Radiol. 2021; 39(11):1023-1038.

PMID: 34125369 PMC: 8202053. DOI: 10.1007/s11604-021-01150-4.


HIV-associated neurodegenerative disorders: extracellular and intracellular mechanisms.

Avdoshina V, Mocchetti I AIDS. 2020; 34(15):2334-2336.

PMID: 33196498 PMC: 7793559. DOI: 10.1097/QAD.0000000000002727.


Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders.

Moulignier A, Costagliola D Curr Top Behav Neurosci. 2020; 50:367-399.

PMID: 31989463 DOI: 10.1007/7854_2019_123.


The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons.

Avdoshina V, Fields J, Castellano P, Dedoni S, Palchik G, Trejo M Neurotox Res. 2016; 29(4):583-593.

PMID: 26936603 PMC: 4821687. DOI: 10.1007/s12640-016-9608-6.